Clinical Trial Update: Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

View source ↗

Summary

A completed real-world evidence study evaluating the effectiveness of paritaprevir/ombitasvir ± dasabuvir ± ribavirin with patient support in chronic hepatitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Dasabuvir (dasabuvir)
• Ribavirin (ribavirin)
• paritaprevir/ombitasvir (paritaprevir/ombitasvir)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C | Status: COMPLETED | Results posted: 2019-10-11